EP1858535A4 - ACTINIDIA COMPOSITIONS AND METHODS OF USE - Google Patents

ACTINIDIA COMPOSITIONS AND METHODS OF USE

Info

Publication number
EP1858535A4
EP1858535A4 EP06735914A EP06735914A EP1858535A4 EP 1858535 A4 EP1858535 A4 EP 1858535A4 EP 06735914 A EP06735914 A EP 06735914A EP 06735914 A EP06735914 A EP 06735914A EP 1858535 A4 EP1858535 A4 EP 1858535A4
Authority
EP
European Patent Office
Prior art keywords
actinidia
compositions
methods
actinidia compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP06735914A
Other languages
German (de)
French (fr)
Other versions
EP1858535A2 (en
Inventor
Julianne Lindemann
George E Stagnitti
Robert H Driver
Mark A Braman
Nancy E Fogg-Johnson
Sunyoung Kim
Mirim Jin
Hyung-Jin Jung
Sung-Seup Shin
Jin-Hwan Oh
Hwa-Jun Lee
Eun-Jin Park
Bongcheol Kim
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
EFFICAS, INC.
Pangenomics Co Ltd
Original Assignee
Pangenomics Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pangenomics Co Ltd filed Critical Pangenomics Co Ltd
Publication of EP1858535A2 publication Critical patent/EP1858535A2/en
Publication of EP1858535A4 publication Critical patent/EP1858535A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cosmetics (AREA)
EP06735914A 2005-02-25 2006-02-24 ACTINIDIA COMPOSITIONS AND METHODS OF USE Withdrawn EP1858535A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US65683905P 2005-02-25 2005-02-25
US65683805P 2005-02-25 2005-02-25
PCT/US2006/006437 WO2006093793A2 (en) 2005-02-25 2006-02-24 Compositions comprising actinidia and methods of use thereof

Publications (2)

Publication Number Publication Date
EP1858535A2 EP1858535A2 (en) 2007-11-28
EP1858535A4 true EP1858535A4 (en) 2012-05-02

Family

ID=36941647

Family Applications (1)

Application Number Title Priority Date Filing Date
EP06735914A Withdrawn EP1858535A4 (en) 2005-02-25 2006-02-24 ACTINIDIA COMPOSITIONS AND METHODS OF USE

Country Status (8)

Country Link
EP (1) EP1858535A4 (en)
JP (1) JP2008531584A (en)
AU (1) AU2006218875B2 (en)
BR (1) BRPI0608042A2 (en)
MX (1) MX2007010408A (en)
RU (1) RU2423139C2 (en)
TW (1) TWI385007B (en)
WO (1) WO2006093793A2 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080175888A1 (en) * 2005-02-25 2008-07-24 Julie Lindemann Combination Therapy Comprising Actinidia and Steroids and Uses Thereof
DE102006055210A1 (en) * 2006-11-21 2008-05-29 Ionescu, John G., Dr. Dietary food with increased free radical binding effect
KR101141182B1 (en) 2009-05-12 2012-05-02 재단법인 제주테크노파크 Composition for Anti-inflammation
US9352008B2 (en) 2009-08-12 2016-05-31 Melaleuca, Inc. Dietary supplements and methods for treating pain and inflammation
JP4750202B2 (en) * 2009-10-16 2011-08-17 株式会社 藍匠 Method for producing health supplements using Sarnashi
ES2634034T5 (en) * 2009-12-29 2020-09-18 Nestle Sa Nutritional compositions with fruit flakes containing docosahexenoic acid
JP5688233B2 (en) * 2010-04-23 2015-03-25 ポーラ化成工業株式会社 TARC production inhibitor
JP6179840B2 (en) * 2011-11-30 2017-08-16 国立大学法人 岡山大学 Highly polar organic solvent extract from Sarnashi and its utilization
JP6242669B2 (en) * 2013-11-27 2017-12-06 日本メナード化粧品株式会社 Hyaluronic acid production promoter containing a sarnashi extract
CN105410588B (en) * 2015-11-06 2018-05-08 四川兴食尚科技有限公司 A kind of Kiwi berry effervescent tablet and its preparation process
WO2019224200A1 (en) * 2018-05-22 2019-11-28 N.V. Nutricia Biomarkers for improving nutrion for infants at risk
KR102932961B1 (en) * 2023-11-29 2026-03-20 (주)케이에스코리아 Cosmetic Composition for Atopic Dermatitis Improvement and Treatment and Method the Same

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040022914A1 (en) * 2002-06-07 2004-02-05 Allen Ann De Wees Novel sweetener compositions and methods of use
WO2004017982A1 (en) * 2002-08-23 2004-03-04 Pangenomics Co., Ltd Composition comprising the extract of actinidia arguta and related species for the prevention and treatment of allergic disease and non-allergic inflammatory disease

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5242814A (en) * 1989-10-10 1993-09-07 Eli Lilly And Company Polyether antibiotic
RU2186569C2 (en) * 1996-01-23 2002-08-10 Ай-Си-Эн ФАРМАСЬЮТИКАЛЗ Modulation of expression of cytokines th1/th2 by ribavirin and ribavirin analogs in activated t-lymphocytes
US6046185A (en) * 1996-07-11 2000-04-04 Inflazyme Pharmaceuticals Ltd. 6,7-oxygenated steroids and uses related thereto
DE19758090B4 (en) * 1997-12-18 2008-10-16 Maria Endres Composition and its use in cosmetics and medicine
JP2002302458A (en) * 2000-12-26 2002-10-18 Takeda Chem Ind Ltd Combined medicine
EP1263926B1 (en) * 2001-03-29 2006-05-17 Council of Scientific and Industrial Research Process for the preparation of herbal wines from himalayan berries
US6811796B2 (en) * 2002-04-22 2004-11-02 Matsuura Yakugyo Co., Ltd. Preventive or therapeutic agent for pollen allergy, allergic rhinitis, atopic dermatitis, asthma or urticaria, or health food for prevention or improvement or reduction of symptoms thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040022914A1 (en) * 2002-06-07 2004-02-05 Allen Ann De Wees Novel sweetener compositions and methods of use
WO2004017982A1 (en) * 2002-08-23 2004-03-04 Pangenomics Co., Ltd Composition comprising the extract of actinidia arguta and related species for the prevention and treatment of allergic disease and non-allergic inflammatory disease

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
KIM YOO KYUNG ET AL: "Anti-inflammation activity of Actinidia polygama", ARCHIVES OF PHARMACAL RESEARCH, NATL. FISHERIES UNIVERSITY, PUSAN, KR, vol. 26, no. 12, 1 December 2003 (2003-12-01), pages 1061 - 1066, XP002528453, ISSN: 0253-6269, DOI: 10.1007/BF02994759 *

Also Published As

Publication number Publication date
WO2006093793A3 (en) 2006-12-07
JP2008531584A (en) 2008-08-14
WO2006093793A8 (en) 2008-03-27
TW200716226A (en) 2007-05-01
AU2006218875B2 (en) 2012-08-09
EP1858535A2 (en) 2007-11-28
WO2006093793A2 (en) 2006-09-08
MX2007010408A (en) 2008-03-25
BRPI0608042A2 (en) 2009-11-03
TWI385007B (en) 2013-02-11
RU2007135365A (en) 2009-03-27
AU2006218875A1 (en) 2006-09-08
RU2423139C2 (en) 2011-07-10

Similar Documents

Publication Publication Date Title
EP1796537A4 (en) DENDRIMER COMPOSITIONS AND METHODS OF USE THEREOF
EP1838331A4 (en) ANTIMICROBIAL PEPTIDES AND METHODS OF USE THEREOF
EP1762234A4 (en) AMPK ACTIVATOR
EP1812102A4 (en) OCCLUSAL ENDOPROTHESIS AND METHODS OF USE THEREOF
EP1855833A4 (en) PLASMAS AND METHODS OF USE
EP1913112A4 (en) SUPPORTING AGENT AND METHODS OF USE
EP1851335A4 (en) COMPOSITIONS AND METHODS OF USING STANDARD MIXTURES
EP1831207A4 (en) AMINOPYRIMIDINE COMPOUNDS AND METHODS OF USE THEREOF
EP1771786A4 (en) MULTIFRAITEMENT OF SAMPLES
EP1794372A4 (en) IMPACT ATTENUATOR
EP1718120A4 (en) DISPLAY ELEMENT
EP1706791A4 (en) PHOTORESIN COMPOSITIONS AND METHODS OF USE
EP2066817A4 (en) MOLECULAR SWITCHES AND METHODS OF USE
EP1722797A4 (en) ISOQUINOLINE DERIVATIVES AND METHODS OF USE
EP1971600A4 (en) ISOXASOLE DERIVATIVES AND THEIR USE
EP2040541A4 (en) ADJUVANTS AND METHODS OF USE
EP1874731A4 (en) QUINOBENZOXAZINE ANALOGUES AND METHODS OF USE THEREOF
EP1735456A4 (en) POYLMERIC COMPOSITIONS AND ASSOCIATED METHODS OF USE
EP1827464A4 (en) ZINC COMPOSITIONS AND METHODS OF USE
EP1954685A4 (en) FUROXANE COMPOUNDS, COMPOSITIONS AND METHODS OF USE
EP1858535A4 (en) ACTINIDIA COMPOSITIONS AND METHODS OF USE
EP1817055A4 (en) ANTI-OVR110 ANTIBODY COMPOSITIONS AND CORRESPONDING METHODS OF USE
EP1701948A4 (en) TEST OF ENTACTOGENES
EP1812012A4 (en) PROTEIN-TYROSINE-PHOSPHATASE INHIBITORS AND METHODS OF USE THEREOF
EP1814977A4 (en) ARTHROSPIRA COMPOSITIONS AND USES THEREOF

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20070924

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: EFFICAS, INC.

Owner name: PANGENOMICS CO., LTD.

R17D Deferred search report published (corrected)

Effective date: 20080327

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20120403

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 36/00 20060101AFI20120328BHEP

Ipc: A61P 11/06 20060101ALI20120328BHEP

Ipc: A61P 37/08 20060101ALI20120328BHEP

17Q First examination report despatched

Effective date: 20130411

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20130903